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Research
There have been several studies on the short-
term effects of air pollution on hospital admis-
sions (Burnett et al. 1997a, 1997b; Le Tertre et
al. 2002; Pope 2000; Samet et al. 2000), but
most have examined single cities. Such single-
city studies have been criticized for being
applicable only to the city under study and for
using different modeling approaches. These
comments have led to multicity meta-analyses
where the results are pooled—for example, the
National Morbidity, Mortality, and Air
Pollution Study (NMMAPS) conducted on
behalf of the Health Effects Institute in the
United States and the APHEA (Air Pollution
and Health: A European Approach) studies in
Europe. NMMAPS examined the associations
between daily hospital counts for cardiovascular
admissions in the elderly and air pollutants in
14 cities in different regions of the United
States (Dominici et al. 2002b; Samet et al.
2000). The APHEA studies have taken place in
two stages, and the latest (APHEA2) comprised
eight European cities in the investigation of
associations of air pollution on daily cardiovas-
cular admissions (Le Tertre et al. 2002).
Multicity studies have also been conducted in
Canada (Burnett et al. 1997a, 1997b).
Despite these studies, the strength of the
association between outdoor air pollution and
health effects is still unclear because of the
complexity of the time-series modeling. In
addition, when multiple pollutants have been
examined, the independent effects of each pol-
lutant are usually addressed in multipollutant
models, but these are sensitive to the modeling
assumptions. If the association with one pollu-
tant is nonlinear or varies by season, then a
two-pollutant model assuming a linear rela-
tionship with each pollutant might not give
the independent effect of the second pollutant.
Therefore, the case–crossover design (Maclure
1991), which is less sensitive to model assump-
tions, is more appropriate. This method inves-
tigates the effects of acute exposures and can
also examine both multiple exposures and
interactions between exposures. It has been
applied to the analysis of the acute effects of
environmental exposures, especially air pollu-
tion (Sunyer et al. 2000). The method
matches case days to nearby control days and
hence controls for covariates that change
slowly over time (e.g., age, smoking behavior,
and usual diet). Such matching also controls
for seasonal variation and time trends in the
health event (Bateson and Schwartz 2001).
In this study we aimed to find associa-
tions between outdoor air pollutant and car-
diovascular disease (as measured by counts of
hospital admissions) in cities in Australia and
New Zealand. The study used two age groups,
≥ 65 years of age (elderly) and 15–64 years of
age, although the focus here is on the elderly.
The study also examined differences in the
associations between cities.
Materials and Methods
Data collection. Daily hospital and pollution
data were collected for the years 1998 through
2001 in five of the largest cities in Australia
(Brisbane, Canberra, Melbourne, Perth,
Sydney) and two cities in New Zealand
(Auckland, Christchurch). In 2001, these cities
covered 53% of the Australian population
and 44% of the New Zealand population.
Cardiovascular health data and air
pollution data. Health data were collected for
all cardiovascular emergency hospital admis-
sions from state government health depart-
ments in Australia and the New Zealand
Health Information Service (Ministry of
Health). The cardiovascular disease categories
used in the study are shown in Table 1, and
summary statistics and demography for each
city are shown in Table 2.
The pollutants considered were particu-
late matter < 2.5 µm in diameter (PM2.5) and
< 10 µm in diameter (PM10) in micrograms
per cubic meter; nitrogen dioxide in parts per
billion; carbon monoxide in parts per mil-
lion; and ozone in parts per billion. Tapered
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OBJECTIVE: The goal of this study was to estimate the associations between outdoor air pollution
and cardiovascular hospital admissions for the elderly. 
DESIGN: Associations were assessed using the case–crossover method for seven cities: Auckland and
Christchurch, New Zealand; and Brisbane, Canberra, Melbourne, Perth, and Sydney Australia. Results
were combined across cities using a random-effects meta-analysis and stratiﬁed for two adult age
groups: 15–64 years and ≥ 65 years of age (elderly). Pollutants considered were nitrogen dioxide, car-
bon monoxide, daily measures of particulate matter (PM) and ozone. Where multiple pollutant associa-
tions were found, a matched case–control analysis was used to identify the most consistent association. 
RESULTS: In the elderly, all pollutants except O3 were signiﬁcantly associated with ﬁve categories of
cardiovascular disease admissions. No associations were found for arrhythmia and stroke. For a 0.9-
ppm increase in CO, there were signiﬁcant increases in elderly hospital admissions for total cardio-
vascular disease (2.2%), all cardiac disease (2.8%), cardiac failure (6.0%), ischemic heart disease
(2.3%), and myocardial infarction (2.9%). There was some heterogeneity between cities, possibly
due to differences in humidity and the percentage of elderly people. In matched analyses, CO had
the most consistent association. 
CONCLUSIONS: The results suggest that air pollution arising from common emission sources for
CO, NO2, and PM (e.g., motor vehicle exhausts) has signiﬁcant associations with adult cardiovas-
cular hospital admissions, especially in the elderly, at air pollution concentrations below normal
health guidelines. 
RELEVANCE TO CLINICAL AND PROFESSIONAL PRACTICE: Elderly populations in Australia need to be
protected from air pollution arising from outdoor sources to reduce cardiovascular disease. 
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[Online 13 March 2006]element oscillating microbalance (TEOM)
air samplers provided the PM data. Daily
pollutant levels were calculated by averaging
over a network of monitors in each city. The
summary statistics for air pollutants and
weather are shown in Table 3.
CO and NO2 were the only pollutants
monitored in all seven cities on a daily basis.
For PM2.5, daily measurements were available
in four of the Australian cities: Brisbane,
Melbourne, Perth, and Sydney. PM10 was
measured on a daily basis in these four cities
and in Christchurch.
Statistical methods. We used the time-
stratiﬁed case–crossover method to ﬁnd asso-
ciations between pollutants and daily counts
of hospital admissions (Janes et al. 2005).
Controls were chosen from strata of length 28
days; days either side of the case day were
excluded to reduce the correlation between
case and control exposure. The method con-
trolled for long-term trend, seasonal changes,
and respiratory epidemics by design. Using
covariates, there were additional controls for
temperature, current minus previous day’s
temperature, relative humidity, pressure,
extremes of hot and cold (coldest and
warmest 1% of days), day of the week, public
holiday (yes/no), and day after a public holi-
day(s) (yes/no). Rainfall was also included in
some investigational models.
The pollutant exposure was the average of
the current and previous day. Changes in
admissions are shown for a one interquartile
range (IQR) increase in pollutant, using the
mean IQR across cities. This makes the
increases from different pollutants more com-
parable. An IQR increase can be thought of as
the difference between a moderately good day
and a moderately bad day. The IQRs were
3.8 µg/m3 for 24-hr PM2.5, 7.5 µg/m3 for 24-
hr PM10, 5.1 ppb for 24-hr NO2, 0.9 ppm
for 8-hr CO, and 8.8 ppb for 8-hr O3.
To estimate the average effect for all cities,
we combined the estimates across cities using
a random effects meta-analysis (Normand
1999) and quantiﬁed the differences (hetero-
geneity) between cities using the I2 statistic
(Higgins and Thompson 2002). I2 values
> 80% indicate that differences between cities
are high; > 50%, notable; > 20%, mild; and
< 20%, small. To test whether one city had
an undue inﬂuence on the meta-analysis, we
used a leave-one-city-out sensitivity analysis
(Normand 1999).
We examined differences in the increases
between cities using a hierarchical model to
incorporate variables that differ between cities
and therefore could modify the results (effect
modifiers) (Dominici et al. 2002a). The
increases in admissions in each city were
regressed against potential city-level effect
modiﬁers such as average pollutant level, tem-
perature, and percentage of the population
≥ 65 years of age. Differences were examined
only where there was notable heterogeneity
(deﬁned by I2 > 50%).
When a health outcome showed a signiﬁ-
cant association with more than one pollutant,
we ran a multipollutant model using a matched
case–crossover approach (Schwartz 2004).
Matching is a traditional approach to control
for potential confounding in epidemiology.
With control days that are both close in time to
the case day and also matched on the level of
another pollutant, the effect estimate cannot be
confounded by the other pollutant. Matched
control days were defined as 24-hr PM2.5
within 2 µg/m3, 24-hr PM10 within 3 µg/m3,
24-hr NO2 within 1 ppb, 24-hr CO within 0.5
ppm, and temperature within 1°C.
All analyses were conducted using SAS
software (SAS Institute Inc. 2001).
In the absence of an a priori opinion of
which pollutants were important to health, we
used a statistical signiﬁcance level of 5%, with
no correction for multiple comparisons.
Although this increased the chances of ﬁnding
spurious associations, it reduced the chances of
missing any important associations during this
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Table 1. Cardiovascular disease categories and International Classiﬁcation of Disease (ICD) codes.
Disease category ICD-9 ICD-10
Arrhythmia 427 I46–I49
Cardiac disease 390–429 I00–I52, I97.0, I97.1, I98.1
Cardiac failure 428 I50
Ischemic heart disease 410–413 I20, I21, I22, I24, I25.2
Myocardial infarction 410 I21, I22
Stroke 430–438 I60–I66, I67 (excluding I67.0, I67.3), I68 (excluding
I68.0), I69, G45 (excluding G45.3), G46
Total cardiovascular disease 390–459 I00–I99 (excluding I67.3, I68.0, I88, I97.8, I97.9, I98.0),
G45 (excluding G45.3), G46, M30, M31, R58
ICD-9, 9th Revision, used January–June 1998; ICD-10, 10th Revision, used July 1998–December 2001.
Table 2. Summary statistics for demographic and hospital admission rates per million people (1998–2001).
Auckland Brisbane Canberra Christchurch Melbourne Perth Sydney
Demographic data
Total population 1,158,891 1,627,535 311,518 316,224 3,366,542 1,339,993 3,997,321
Percentage of population > 65 years 10.0 11.0 8.3 13.7 12.1 11.3 11.9
Daily hospital admissions [mean (range)]
Cardiovascular
15–64 years 11.5 (3–31) 9.3 (2–19) 17.6 (0–67) 10.2 (0–32) 7.7 (2–14) 7.9 (1–17) 7.7 (3–14)
≥ 65 years 18.1 (4–35) 18.6 (8–33) 20.0 (0–61) 26.2 (0–60) 16.3 (8–28) 18.8 (6–35) 15.5 (7–26)
Cardiac
15–64 years 8.6 (1–24) 7.5 (1–17) 10.5 (0–42) 7.3 (0–28) 5.5 (1–11) 6.0 (0–14) 5.9 (2–11)
≥ 65 years 12.8 (2–27) 14.0 (5–29) 14.1 (0–45) 18.1 (0–44) 11.5 (5–21) 13.7 (3–27) 11.1 (5–20)
Ischemic heart disease
15–64 years 4.5 (0–14) 4.5 (0–11) 4.8 (0–26) 4.5 (0–19) 3.2 (1–6) 3.4 (0–9) 3.1 (0–7)
≥ 65 years 6.5 (0–18) 7.6 (1–18) 6.1 (0–26) 10.4 (0–35) 5.7 (2–11) 6.7 (1–15) 4.9 (2–10)
Stroke
15–64 years 1.6 (0–7) 0.9 (0–6) 1.0 (0–10) 1.8 (0–13) 1.1 (0–3) 1.0 (0–5) 1.0 (0–3)
≥ 65 years 3.5 (0–10) 3.2 (0–9) 2.6 (0–16) 5.5 (0–22) 3.5 (1–10) 3.4 (0–9) 3.1 (1–7)
Arrhythmia
15–64 years 2.0 (0–9) 1.3 (0–6) 2.0 (0–19) 1.3 (0–13) 1.0 (0–4) 1.1 (0–6) 1.2 (0–4)
≥ 65 years 2.5 (0–9) 2.1 (0–7) 2.5 (0–16) 2.7 (0–16) 1.8 (0–5) 2.2 (0–7) 1.9 (0–5)
Cardiac failure
15–64 years 0.8 (0–5) 0.5 (0–3) 0.4 (0–6) 0.4 (0–9) 0.5 (0–3) 0.5 (0–4) 0.4 (0–2)
≥ 65 years 2.7 (0–10) 3.2 (0–10) 2.3 (0–13) 3.7 (0–22) 3.3 (1–7) 3.7 (0–12) 2.9 (0–9)
Myocardial infarction
15–64 years 1.5 (0–7) 1.4 (0–5) 1.2 (0–10) 1.8 (0–13) 1.2 (0–4) 1.3 (0–5) 1.1 (0–3)
≥ 65 years 2.3 (0–9) 2.4 (0–7) 1.4 (0–13) 4.7 (0–25) 1.9 (0–6) 2.4 (0–9) 1.7 (0–4)early stage of investigation of the effects of air
pollution in Australia and New Zealand.
In this study we used monitoring data pro-
vided by the relevant monitoring agency in
each city. The data sets have been used with-
out extensive analysis or corrections beyond
the basic quality control needed to ensure data
validity for the case–crossover analysis. Some
data sets were not fully used (e.g., the PM10
data from Auckland) because they did not
fully meet the strict requirements of the study
but are still regarded as valid data sets for the
purposes for which they were gathered.
Results
The associations between pollutants and car-
diovascular hospital admissions are shown in
Table 4. In the elderly, signiﬁcant associations
were found between the pollutants CO, NO2,
and PM and ﬁve categories of cardiovascular
disease admissions. Arrhythmia showed no
associations in the elderly but did in the 15- to
64-year age group. Stroke was the only disease
category to show no associations in either age
group. O3 was the only pollutant to show
no associations.
In elderly admissions, the two largest sta-
tistically signiﬁcant increases were for cardiac
failure, with a 6.9% increase for a 5.1-ppb
unit increase in NO2 and a 6.0% increase for
a 0.9-ppm increase in CO.
For the elderly age group, the relative risks
for all cardiac admissions associated with CO,
NO2, PM2.5, and PM10 are shown for each
city and the meta-analysis in Figure 1, which
highlights some of the differences in risk
among the cities. This heterogeneity is quan-
tified by the I2 statistics in Table 4. The I2
statistics indicate that more than half of the
results had small heterogeneity. Notable het-
erogeneity was more often observed in the
elderly group.
Table 5 shows a much reduced I2 when
Sydney was left out for the association
between CO and cardiac admissions. Figure
1A shows that the association in Sydney was
much larger than in the other cities. The
association was also larger in Perth, but the
conﬁdence intervals (CIs) were wider. Table 5
and Figure 1B show that when Christchurch
was left out, the association between NO2
and cardiac admissions was similar for the
remaining cities.
Statistically signiﬁcant effect modiﬁers were
found only for associations with PM2.5. For
cardiac admissions, there was a greater associa-
tion with PM2.5 in cities with less humidity.
For cardiac failure, there was a greater associa-
tion with PM2.5 in cities with higher pressure
and a greater percentage of elderly.
Multipollutant results using a matched
case–crossover analysis are shown in Table 6.
None of the estimated increases changed
greatly when cases and controls were matched
on temperature. The estimated increase due
to NO2 fell greatly when cases and controls
were matched on CO.
Discussion
Cardiovascular admissions in the elderly. This
study found many associations between air
pollution and cardiovascular admissions in
cities in Australia and New Zealand. For every
condition but arrhythmia, the increases in
hospital admissions were greater in the elderly
than in the younger age group (Table 4), most
likely because the elderly are a frailer popula-
tion with probable preexisting heart problems.
The frailty of the elderly is also the most likely
reason that they did not show increases in
arrhythmia. Arrhythmia and cardiac failure are
related conditions because atrial ﬁbrillation is
a type of arrhythmia and may precipitate car-
diac failure in elderly people (Cowie et al.
1999). Hence, exposure to NO2 and CO that
led to arrhythmia in the younger age group led
to the more serious condition of cardiac failure
in the elderly.
We found associations at concentrations
below normal air quality health guidelines
(Table 3). This suggests that current air pollu-
tion guidelines need to be revised. There is
good reason to believe that lowering air pollu-
tion levels would lead to improvements in
cardiovascular health.
This results presented here are based on
statistically signiﬁcant ﬁndings. Although this
is not ideal practice, there is limited space in
this article; a complete set of results will be
available in a forthcoming report (Expansion
of the Multi-City Mortality and Morbidity
Study, National Environment Protection
Council). A non-statistically signiﬁcant associ-
ation does not, of course, mean that a rela-
tionship does not exist. This is particularly
important for those admissions with smaller
numbers of events and hence less power (e.g.,
stroke in the younger age group).
Differences among cities. Differences in
the associations between cities in this study
were mostly not notable (I2 < 50%). This
suggests that the relationship between expo-
sure and disease was often similar. There was
more notable heterogeneity in the elderly
population, which is partly due to the greater
size of the associations in this age group.
In an attempt to explain the notable
heterogeneity, we used effect-modiﬁer analy-
ses. However, we found effect modiﬁers only
for associations with PM2.5. The effect of
PM2.5 in Australian cities depended on the
percentage of the elderly and average weather
conditions. Less average humidity and higher
average pressure led to a greater association.
To investigate these modiﬁcations further, we
reran the case–crossover models in each city
Barnett et al.
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Table 3. Summary statistics for daily air pollutant and weather data (1998–2001).
Auckland Brisbane Canberra Christchurch Melbourne Perth Sydney
Daily pollutant levels [mean (range)]
24-hr PM2.5 (µg/m3) 11.0a (2.1–37.6) 9.7 (3.2–122.8) —  — 8.9 (2.8–43.3) 8.1 (1.7–29.3) 9.4 (2.4–82.1)
No. of monitors 1 1 0 0 2 2 3
24-hr PM10 (µg/m3) 18.8a (3.2–101.4) 16.5 (3.8–50.2) —  20.6 (1.3–156.3) 16.6 (3.1–71.1) 16.5 (4.4–68.9) 16.6 (3.7–104.7)
No. of monitors 6 4 0 2 4 1 11
1-hr NO2 (ppb) 19.1 (4.2–86.3) 17.3 (4–44.1) 17.9 (0–53.7) 15.7 (1.2–54.6) 23.2 (4.4–62.5) 21.3 (4.4–48) 22.6 (5.2–51.4)
24-hr NO2 (ppb) 10.2 (1.7–28.9) 7.6 (1.4–19.1) 7.0 (0–22.5) 7.1 (0.2–24.5) 11.7 (2–29.5) 9.0 (2–23.3) 11.5 (2.5–24.5)
No. of monitors 2 7 1 1 8 5 13
8-hr CO (ppb) 2.1 (0.2–7.9) 1.7 (0–7) 0.9 (0–5.8) 0.5 (0–5.4) 1.0 (0.1–8) 1.0 (0.1–4) 0.8 (0–4.5)
No. of monitors 3 1 1 2 3 3 4
1-hr O3 (ppb) —  31.5 (7–92.3) —  —  23.8 (1.7–85.4) 33.6 (13–85) 31.7 (3.2–126.7)
4-hr O3 (ppb) —  28.9 (5.4–75.2) —  —  21.8 (1.3–73.1) 31.3 (10.6–72.8) 28.9 (2.2–105.1)
8-hr O3 (ppb) —  25.5 (3.7–58.4) —  —  19.0 (0.8–63) 28.5 (8–64) 24.9 (1.4–86.8)
No. of monitors 0 7 0 0 8 3 12
Weather
Temperature (°C) 15.7 (6.3–24.1) 20.0 (9.5–30.4) 13.7 (1–28) 11.6 (0–27.2) 15.3 (5.9–31.8) 18.2 (8.2–32.3) 17.8 (8.5–30.1)
Relative humidity (%) 79.1 (52.1–100) 72.4 (29.3–96.3) 69.9 (24.1–97) 75.9 (31–99) 68.7 (25.1–95.5) 67.8 (28–98.5) 70.6 (26.3–97.1)
Rain (mm) 3.06 (0–71.6) 2.6 (0–128.9) 1.82 (0–79.8) 1.56 (0–54.8) 1.99 (0–43.07) 2.08 (0–104.0) 2.71 (0–137.1)
aThe Auckland region does not run TEOMs but had an extensive Hi-Vol network. The PM data for Auckland were recorded once every 6 days and were not suitable for the
case–crossover analysis.including an interaction term for 24-hr PM2.5
and rainfall (results not shown). Higher rain-
fall led to a smaller association between car-
diovascular admissions and PM2.5 in all four
cities. This is not surprising, considering
that rainfall is a primary removal mechanism
for PM10 and PM2.5, but less so for gaseous
pollutants.
Comparison with three other large studies.
The aim and design of this study were similar
to those of three other large studies: the
APHEA2 study of eight cities in Europe (Le
Tertre et al. 2002), NMMAPS with 14 U.S.
cities (Samet et al. 2000), and a Canadian
study of 10 cities (Burnett et al. 1997b). The
results here for PM pollution in terms of
elderly cardiac admissions are similar to those
found in APHEA2 and NMMAPS, and con-
gestive heart failure in the Canadian study.
For example, we found the mean increase for
cardiac admissions for the 15–64-year age
group to be less than half that in the older
group, a result similar to that of the APHEA2
study. The APHEA2 study also found that
the heterogeneity in total cardiac admissions
(all ages) was related to the percentage of
elderly. However, the results for the con-
founding effects on PM associations by
including CO are different (but PM was not
monitored in every city here).
A difference between this study and the
three large multicity studies is that emission
sources for PM, and therefore the PM com-
position, differ. For example, Chan et al.
(1999) found significantly higher contribu-
tions from sea salt and nonanthropogenic
crustal sources for both PM2.5 and PM10 in
Brisbane than in overseas cities.
Another important difference from the
other studies is in the statistical methods used
here. The NMMAPS and APHEA2 studies
used generalized additive models, in which
confounding was estimated by adding the
copollutant into the model. In the APHEA2
study, the PM10 associations were signiﬁcantly
reduced in the multipollutant models by the
inclusion of NO2 (as found here) and slightly
(but becoming statistically insignificant) for
CO. However, using black smoke to estimate
the PM impacts showed no confounding by
CO and much less by NO2. There was no sig-
niﬁcant confounding of the PM associations
by CO or NO2 found in NMMAPS.
Addressing confounding between pollu-
tants. Instead of using a multipollutant
model, we controlled for confounding by
matching in the case–crossover analysis. For
elderly hospital admissions, the CO associa-
tions remained of a similar size when matched
with NO2. Conversely, the NO2 became
smaller when matched with CO (Table 6).
Matching was also used to control for the
important confounder of temperature. The
results changed little when matched on
temperature, strongly suggesting that the asso-
ciation between air pollution and cardiovascu-
lar disease is not confounded by temperature.
Is outdoor air pollution a good indicator
of exposure? A problem in interpreting the
results from this study is that it used outdoor
air pollution concentrations measured at ﬁxed-
point monitors (ambient concentrations),
whereas people spend most of their time
indoors. Recent studies in Baltimore, Maryland
(Sarnat et al. 2001) and Boston, Massachusetts
(Sarnat et al. 2005) indicate that such ambient
concentrations may be poor surrogates for
actual exposure to air pollution, especially
in winter when buildings are more sealed.
However, winters in Australia are mild, mean-
ing that people will likely spend more time
outdoors and that houses are designed to lose
heat rather than trap it. Hence, exposure to
the air may be high all year round in Australia
Air pollution and the elderly
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Figure 1. Estimated increases (mean and 95% CI) for cardiac admissions in the elderly by city for four
pollutants (average lag, 0–1; one IQR increase). (A) Maximum 8-hr CO. (B) Average 24-hr NO2. (C) Average
24-hr PM2.5. (D) Average 24-hr PM10.
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Table 4. Signiﬁcant increases in cardiovascular hospital admissions by age group using a meta-analysis of
case–crossover estimates (urban Australia and New Zealand, 1998–2001).
Elderly (≥ 65 years) Adults (15–64 years)
Disease category Pollutant (units) Increase [%a (95% CI)] I2 (%)b Increase [%a (95% CI)] I2(%)b
Arrhythmia 24-hr NO2 (ppb) 0.4 (–1.8 to 2.6) 0 5.1 (2.2 to 8.1) 0
8-hr CO (ppm) 0.1 (–1.8 to 2.1) 10.8 2.5 (0.1 to 4.9) 5.6
Cardiac 24-hr PM2.5 (µg/m3)c 1.9 (1.0 to 2.7) 55.0 0.6 (–0.2 to 1.4) 0
24-hr PM10 (µg/m3)c 1.1 (0.2 to 2.0) 32.9 0.3 (–0.8 to 1.3) 0
24-hr NO2 (ppb) 3.4 (1.9 to 4.9) 54.1 2.2 (0.9 to 3.4) 0
8-hr CO (ppm) 2.8 (1.3 to 4.4) 73.5 1.7 (0.5 to 2.9) 24.7
Cardiac failure 24-hr PM2.5 (µg/m3)c 3.6 (1.8 to 5.4) 58.6 3.0 (–0.1 to 6.1) 0
24-hr PM10 (µg/m3)c 3.4 (2.1 to 4.7) 0 2.1 (–1.7 to 6.1) 0
24-hr NO2 (ppb) 6.9 (2.2 to 11.8) 61.3 4.6 (0.1 to 9.3) 0
8-hr CO (ppm) 6.0 (3.5 to 8.5) 61.6 4.2 (0.6 to 7.8) 0
Ischemic heart disease 24-hr PM2.5 (µg/m3)c 1.6 (0.7 to 2.4) 3.6 0.2 (–0.9 to 1.3) 0
24-hr NO2 (ppb) 2.5 (1.0 to 4.1) 19.7 0.7 (–1.0 to 2.4) 0
8-hr CO (ppm) 2.3 (0.9 to 3.8) 35.9 1.6 (–0.6 to 3.9) 53.5
Myocardial infarction 24-hr PM2.5 (µg/m3)c 2.7 (1.3 to 4.2) 0 1.2 (–0.6 to 3.1) 0
24-hr NO2 (ppb) 4.4 (1.0 to 8.0) 38.2 1.7 (–1.1 to 4.7) 0
8-hr CO (ppm) 2.9 (0.8 to 4.9) 21.3 1.8 (–0.7 to 4.3) 9.2
Total cardiovascular 24-hr PM2.5 (µg/m3)c 1.3 (0.6 to 2.0) 51.9 0.2 (–0.5 to 0.9) 0
24-hr NO2 (ppb) 3.0 (2.1 to 3.9) 18.4 1.7 (0.6 to 2.8) 0
8-hr CO (ppm) 2.2 (0.9 to 3.4) 69.5 1.2 (0.3 to 2.1) 6.6
CI, conﬁdence interval.
aPercent increase in admissions for an IQR increase in pollutant using the average over the current and previous day. bI2
is the percentage of total variation in the estimated increase that is due to heterogeneity between cities. cPM2.5 was
measured on a daily basis only in Brisbane, Melbourne, Perth, and Sydney; and PM10, in these cities and Christchurch.(winter exposure in New Zealand may be
more similar to that in Baltimore). A similar
conclusion was drawn by a study of the effects
of cold temperatures on cardiovascular disease
(Barnett et al. 2005). In that study, regions
with mild winters showed greater increases in
cold-related cardiovascular events than did
regions with usually cold winters.
The study in Baltimore also found that
ambient concentrations for CO and NO2
were often better surrogates for actual expo-
sure to PM than to CO and NO2, especially
in summer (Sarnat et al. 2001). However, the
more recent Boston study did note that there
were some correlations between ambient con-
centrations and actual exposure to these gases
in summer (Sarnat et al. 2005). Outdoor con-
centrations for pollutants such as NO2, CO,
and PM often arise from the same combustion
emissions sources, such as motor exhausts.
CO as a marker for pollution sources.
There is evidence that air pollutants (NO2,
CO) may trigger ﬁbrillation in people with a
history of serious arrhythmia (Peters et al.
2000). The effect of CO on cardiovascular
disease is well known, with CO replacing oxy-
gen in the blood stream, but at the low CO
concentrations prevailing in the cities under
study, it cannot be simply assumed that if CO
is the “cause” of any effects found here, it is
due to this mechanism. The associations
found for CO, NO2, and PM are not addi-
tive, but probably refer to the impacts of a
similar pollutant “mix.” Given that the CO
associations show the least change when
matched with the other pollutants (Table 6),
this indicates that the air pollutant mixture
arising from emission sources dominating the
CO emissions (usually human combustion
sources) is the primary cause of the associa-
tion, not the effect of CO itself.
Conclusions
For both Australian and New Zealand cities,
the results show that increases in outdoor
concentrations of CO, NO2, and PM have
significant associations with increases in car-
diovascular admissions for adults, especially
the elderly (≥ 65 years of age). Associations
were found at concentrations below normal
air quality health guidelines. There were sig-
nificant associations between air pollution
and arrhythmia admissions in the younger age
group, which were not apparent for the
elderly. For the elderly, there were signiﬁcant
associations between air pollution increases
and increases in hospital admissions for
ischemic heart disease and myocardial infarc-
tion, and these were not apparent for the
younger group. Atrial ﬁbrillation can precipi-
tate cardiac failure, especially in the elderly,
and a signiﬁcant relationship has been identi-
ﬁed here in the adult age group (15–64 years)
between increases in hospital admissions for
arrhythmia and increases in air pollution.
The associations for NO2 appear to be
stronger in Australian than in New Zealand
cities, whereas those of CO are similar for cities
in both countries. In Australian cities, PM10
and PM2.5 had a similar association, apart from
that for arrhythmia. These PM2.5 associations
differed among cities due to different climate
conditions for humidity (the lower the humid-
ity, the greater the association).
It is difficult to separate the associations
for different pollutants because there are com-
mon emission sources for CO, NO2, and PM
(e.g., motor vehicle exhausts). Also, outdoor
concentrations are often not good surrogates
for actual exposure, with outdoor levels for
the gases sometimes being good surrogates for
actual exposure to PM, especially in summer.
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—, not collected.
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bI2 is the percentage of total variation in the estimated increase that is due to heterogeneity between cities.
Table 6. Multipollutant models: statistically significant increases in cardiac hospital admissions and
increases after matching for other exposures.
Age group/single pollutant Matched exposure Increase [%a (95% CI)]
Cardiac admissions (15–64 years of age)
24-hr average NO2 8-hr average CO (maximum) –0.0 (–1.6 to 1.5)
Average temperature 2.4 (0.9–4.0)
Unmatched 2.2 (0.9–3.4)
8-hr average CO (max) 24-hr average NO2 2.4 (–1.4 to 6.3)
Average temperature 1.9 (0.6–3.3)
Unmatched 1.7 (0.5–2.9)
Cardiac admissions (≥ 65 years of age)
24-hr average NO2 8-hr average CO (maximum) 0.6 (–1.7 to 3.0)
Average temperature 3.5 (1.7–5.4)
Unmatched 3.4 (1.9–4.9)
24-hr average PM2.5
b 24-hr average NO2 0.4 (–1.7 to 2.5)
8-hr average CO (maximum) 1.2 (0.0–2.4)
Average temperature 1.8 (0.6–3.0)
Unmatched 1.9 (1.0–2.7)
8-hr average CO (maximum) 24-hr average NO2 2.8 (0.2–5.4)
Average temperature 2.6 (0.9–4.4)
Unmatched 2.8 (1.3–4.4)
aPercent increase in admissions for an IQR increase in pollutant using the average over the current and previous day.
bPM2.5 was measured on a daily basis only in Brisbane, Melbourne, Perth, and Sydney; and PM10, in these cities and
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